Area of research
Hematology · Molecular Biology
Research interest
Research interests include Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Histone Deacetylase Inhibitors Research, and Multiple Myeloma Research and Treatments.
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i> -Mutated or <i>KMT2A</i> -Rearranged AML
Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)
MEN1 mutations mediate clinical resistance to menin inhibition
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed <i>IDH2</i>-mutant AML
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Leukemia Cell of Origin Influences Apoptotic Priming and Sensitivity to LSD1 Inhibition